Andreas Jordan Chief Scientific Officer, MagForce Nanotechnologies AG Germany

Dr. Andreas Jordan, born 1959, founded MagForce Nanotechnologies AG and serves on its management board as chief scientific officer, with responsibility for all research and development activities. He began his career with studies in biology at the Free University of Berlin, followed by further studies in biochemistry at the Technical University of Berlin. His highly praised doctoral dissertation in 1993 addressed the production of nanoparticles and their application for cancer therapy. This pioneering work was based on research which began in 1987, long before the subject of nanotechnology had achieved any international significance. He subsequently managed scientific projects for the Berlin’s Virchow Clinic (now Charité) as well as for the Institute for Diagnostic Research, a subsidiary of Schering.

Dr. Jordan has already delivered more than 500 scientific lectures about Nano-Cancer® therapy. He has authored more than 45 articles for peer-reviewed scientific journals and has cleared the way for twelve families of international patents, some of which have been licensed. His contacts to NASA, the National Cancer Institute (NCI), the Institute of Nanotechnology (IoN), the U.S. Food and Drug Administration (FDA), and such renowned U.S. hospitals as the University of California, San Francisco (UCSF), the Cleveland Clinic Foundation (CCF) and Duke University, as well as throughout Asia, continue to provide an essential foundation for his professional activities through the world.